Systemic lupus erythematosus is a multisystem inflammatory disease cha
racterized by antinuclear antibody production. The diagnosis of this d
isease is established on the basis of a constellation of clinical and
serologic features. Therapy is directed to specific disease manifestat
ions and involves an array of antiinflammatory and immunosuppressive a
gents that are administered judiciously to limit toxicity.